Skip to main content
Top
Published in: Virology Journal 1/2010

Open Access 01-12-2010 | Research

Characterization of variants in the promoter of BZLF1 gene of EBV in nonmalignant EBV-associated diseases in Chinese children

Authors: Yingkang Jin, Zhengde Xie, Gen Lu, Shuang Yang, Kunling Shen

Published in: Virology Journal | Issue 1/2010

Login to get access

Abstract

Background

Diseases associated with Epstein-Barr virus (EBV) infections, such as infectious mononucleosis (IM), EBV-associated hemophagocytic lymphohistiocytosis (EBV-HLH) and chronic active EBV infection (CAEBV) are not rare in Chinese children. The association of type 1 or type 2 EBV and variants of the EBV BZLF1 promoter zone (Zp) with these diseases is unclear.

Results

The objective of this study was to investigate the relationship between EBV genotypes (Zp variants and EBV type 1 and 2) and the clinical phenotypes of EBV-associated diseases in Chinese children. The Zp region was directly sequenced in 206 EBV-positive DNA samples from the blood of patients with IM, EBV-HLH, CAEBV, and healthy controls. Type 1 or type 2 EBV was examined by PCR for EBNA2 and EBNA3C subtypes. Four polymorphic Zp variants were identified: Zp-P, Zp-V3, Zp-P4 and Zp-V1, a new variant. The Zp-V3 variant was significantly associated with CAEBV (P ≤ 0.01). The frequency of co-infection with Zp variants was higher in patients with CAEBV and EBV-HLH, compared with IM and healthy controls, mostly as Zp-P+V3 co-infection. Type 1 EBV was predominant in all categories (81.3-95%) and there was no significant difference in the frequency of the EBV types 1 and 2 in different categories (P > 0.05).

Conclusions

Type 1 EBV and BZLF1 Zp-P of EBV were the predominant genotypes in nonmalignant EBV associated diseases in Chinese children and Zp-V3 variant may correlates with the developing of severe EBV infection diseases, such as CAEBV and EBV-HLH.
Appendix
Available only for authorised users
Literature
1.
go back to reference Kieff E, Liebowitz D: Epstein-Barr virus and its replication. In Virology. 2nd edition. Edited by: Fields BN, Knipe DM, Chanock RM, Hirsh MS, Melnick JL, Monath TP, Roizman B. New York, N.Y: Raven Press, Ltd.; 1990:1889-1920. Kieff E, Liebowitz D: Epstein-Barr virus and its replication. In Virology. 2nd edition. Edited by: Fields BN, Knipe DM, Chanock RM, Hirsh MS, Melnick JL, Monath TP, Roizman B. New York, N.Y: Raven Press, Ltd.; 1990:1889-1920.
2.
go back to reference Rickinson AB, Kieff E: Epstein-Barr virus. In Fields virology. Volume 2. 4th edition. Edited by: Knipe DM, Howley PM. Philadelphia: Lippincott. Williams & Wilkins; 2001:2575-2627. Rickinson AB, Kieff E: Epstein-Barr virus. In Fields virology. Volume 2. 4th edition. Edited by: Knipe DM, Howley PM. Philadelphia: Lippincott. Williams & Wilkins; 2001:2575-2627.
3.
go back to reference Dambaugh T, Hennessy K, Chamnankit L, Kieff E: U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc Natl Acad Sci USA 1984, 81: 7632-7636. 10.1073/pnas.81.23.7632PubMedPubMedCentralCrossRef Dambaugh T, Hennessy K, Chamnankit L, Kieff E: U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2. Proc Natl Acad Sci USA 1984, 81: 7632-7636. 10.1073/pnas.81.23.7632PubMedPubMedCentralCrossRef
4.
go back to reference Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A: Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol 1990, 64: 4084-4092.PubMedPubMedCentral Sample J, Young L, Martin B, Chatman T, Kieff E, Rickinson A: Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes. J Virol 1990, 64: 4084-4092.PubMedPubMedCentral
5.
go back to reference Chen HL, Lung ML, Chan KH, Griffin BE, Ng MH: Tissue distribution of Epstein-Barr virus genotypes. J Virol 1996, 70: 7301-7305.PubMedPubMedCentral Chen HL, Lung ML, Chan KH, Griffin BE, Ng MH: Tissue distribution of Epstein-Barr virus genotypes. J Virol 1996, 70: 7301-7305.PubMedPubMedCentral
6.
go back to reference Buck M, Cross S, Krauer K, Kienzle N, Sculley TB: A-type and B-type Epstein-Barr virus differ in their ability to spontaneously enter the lytic cycle. J Gen Virol 1999, 80: 441-445.PubMedCrossRef Buck M, Cross S, Krauer K, Kienzle N, Sculley TB: A-type and B-type Epstein-Barr virus differ in their ability to spontaneously enter the lytic cycle. J Gen Virol 1999, 80: 441-445.PubMedCrossRef
7.
go back to reference Brooks JM, Croom-Carter DS, Leese AM, Tierney RJ, Habeshaw G, Rickinson AB: Cytotoxic T-lymphocyte responses to a polymorphic Epstein-Barr virus epitope identify healthy carriers with coresident viral strains. J Virol 2000, 74: 1801-1809. 10.1128/JVI.74.4.1801-1809.2000PubMedPubMedCentralCrossRef Brooks JM, Croom-Carter DS, Leese AM, Tierney RJ, Habeshaw G, Rickinson AB: Cytotoxic T-lymphocyte responses to a polymorphic Epstein-Barr virus epitope identify healthy carriers with coresident viral strains. J Virol 2000, 74: 1801-1809. 10.1128/JVI.74.4.1801-1809.2000PubMedPubMedCentralCrossRef
8.
go back to reference Gutierrez MI, Ibrahim MM, Dale JK, Greiner TC, Straus SE, Bhatia K: Discrete alterations in the BZLF1 promoter in tumor and non-tumor associated Epstein-Barr virus. J Natl Cancer Inst 2002, 94: 1757-1763.PubMedCrossRef Gutierrez MI, Ibrahim MM, Dale JK, Greiner TC, Straus SE, Bhatia K: Discrete alterations in the BZLF1 promoter in tumor and non-tumor associated Epstein-Barr virus. J Natl Cancer Inst 2002, 94: 1757-1763.PubMedCrossRef
9.
go back to reference Martini M, Capello D, Serraino D, Navarra A, Pierconti F, Cenci T, Gaidano G, Larocca LM: Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas. J Infection 2007, 54: 298-306. 10.1016/j.jinf.2006.04.015CrossRef Martini M, Capello D, Serraino D, Navarra A, Pierconti F, Cenci T, Gaidano G, Larocca LM: Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas. J Infection 2007, 54: 298-306. 10.1016/j.jinf.2006.04.015CrossRef
10.
go back to reference Hamblin TJ, Hussain J, Akbar AN, Tang YC, Smith JL, Jones DB: Immunological reason for chronic ill health after infectious mononucleosis. Br Med J 1983, 287: 85-88. 10.1136/bmj.287.6385.85CrossRef Hamblin TJ, Hussain J, Akbar AN, Tang YC, Smith JL, Jones DB: Immunological reason for chronic ill health after infectious mononucleosis. Br Med J 1983, 287: 85-88. 10.1136/bmj.287.6385.85CrossRef
11.
go back to reference Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G: HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007, 48: 124-131. 10.1002/pbc.21039PubMedCrossRef Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, Ladisch S, McClain K, Webb D, Winiarski J, Janka G: HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007, 48: 124-131. 10.1002/pbc.21039PubMedCrossRef
12.
go back to reference Okano M, Kawa K, Kimura H, Yachie A, Wakiguchi H, Maeda A, Imai S, Ohga S, Kanegane H, Tsuchiya S, Morio T, Mori M, Yokota S, Imashuku S: Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol 2005, 80: 64-69. 10.1002/ajh.20398PubMedCrossRef Okano M, Kawa K, Kimura H, Yachie A, Wakiguchi H, Maeda A, Imai S, Ohga S, Kanegane H, Tsuchiya S, Morio T, Mori M, Yokota S, Imashuku S: Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection. Am J Hematol 2005, 80: 64-69. 10.1002/ajh.20398PubMedCrossRef
13.
go back to reference Christensson B, Braconier JH, Winqvist I, Relander T, Dictor M: Fulminant course of infectious mononucleosis with virus-associated hemophagocytic syndrome. Scand J Infect Dis 1987, 19: 373-379. 10.3109/00365548709018485PubMedCrossRef Christensson B, Braconier JH, Winqvist I, Relander T, Dictor M: Fulminant course of infectious mononucleosis with virus-associated hemophagocytic syndrome. Scand J Infect Dis 1987, 19: 373-379. 10.3109/00365548709018485PubMedCrossRef
14.
go back to reference Imashuku S: Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol 1997, 66: 135-151. 10.1016/S0925-5710(97)00584-7PubMedCrossRef Imashuku S: Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. Int J Hematol 1997, 66: 135-151. 10.1016/S0925-5710(97)00584-7PubMedCrossRef
15.
go back to reference Ross CW, Schnitzer B, Weston BW, Hanson CA: Chronic active Epstein-Barr virus infection and virus-associated hemophagocytic syndrome. Arch Pathol Lab Med 1991, 115: 470-474.PubMed Ross CW, Schnitzer B, Weston BW, Hanson CA: Chronic active Epstein-Barr virus infection and virus-associated hemophagocytic syndrome. Arch Pathol Lab Med 1991, 115: 470-474.PubMed
16.
go back to reference Tong JHM, Lo WK, Au FWL, Huang D, To ReK: Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus. J Natl Cancer Inst 2003, 95: 1008-1009.PubMedCrossRef Tong JHM, Lo WK, Au FWL, Huang D, To ReK: Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus. J Natl Cancer Inst 2003, 95: 1008-1009.PubMedCrossRef
17.
go back to reference Chen ML, Tsau CN, Liang CL, Shu CH, Huang CR, Suliltzeanu D, Shih TL, Chang YS: Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 1992, 7: 2131-2140.PubMed Chen ML, Tsau CN, Liang CL, Shu CH, Huang CR, Suliltzeanu D, Shih TL, Chang YS: Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 1992, 7: 2131-2140.PubMed
18.
go back to reference Hu LF, Zabarovsky ER, Chen F, Cao SL, Ernberg I, Klein G, Winberg G: Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 1991, 72: 2399-2409. 10.1099/0022-1317-72-10-2399PubMedCrossRef Hu LF, Zabarovsky ER, Chen F, Cao SL, Ernberg I, Klein G, Winberg G: Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma. J Gen Virol 1991, 72: 2399-2409. 10.1099/0022-1317-72-10-2399PubMedCrossRef
19.
go back to reference Craigs D, Thmas C, Shigeru T: Diagnosis of Epstein-Barr virus-associated diseases. Cri Rev Onc 2002, 40: 37-38. Craigs D, Thmas C, Shigeru T: Diagnosis of Epstein-Barr virus-associated diseases. Cri Rev Onc 2002, 40: 37-38.
20.
go back to reference Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, Kawa K, Morishima T: Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 2001, 98: 280-286. 10.1182/blood.V98.2.280PubMedCrossRef Kimura H, Hoshino Y, Kanegane H, Tsuge I, Okamura T, Kawa K, Morishima T: Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood 2001, 98: 280-286. 10.1182/blood.V98.2.280PubMedCrossRef
21.
go back to reference Khanim F, Yao QY, Niedobitek G, Rickinson AB, Young LS: Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood 1996, 88: 3491-3501.PubMed Khanim F, Yao QY, Niedobitek G, Rickinson AB, Young LS: Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood 1996, 88: 3491-3501.PubMed
22.
go back to reference Kingma DW, Weiss WB, Jaffe ES, Kumar S, Frekko K, Raffeld M: Epstein-Barr virus latent membrane protein-1 oncogene deletions: Correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 1996, 88: 242-251.PubMed Kingma DW, Weiss WB, Jaffe ES, Kumar S, Frekko K, Raffeld M: Epstein-Barr virus latent membrane protein-1 oncogene deletions: Correlations with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 1996, 88: 242-251.PubMed
Metadata
Title
Characterization of variants in the promoter of BZLF1 gene of EBV in nonmalignant EBV-associated diseases in Chinese children
Authors
Yingkang Jin
Zhengde Xie
Gen Lu
Shuang Yang
Kunling Shen
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2010
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-7-92

Other articles of this Issue 1/2010

Virology Journal 1/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.